679818-59-8
M95KG522R0
Ofatumumab [USAN:INN:BAN:JAN]
Immunoglobulin G1, anti-(human CD20 (antigen))(human monoclonal HuMax-CD20 heavy chain), disulfide with human monoclonal HuMax-CD20 kappa-chain, dimer
Ofatumumab
HuMax-CD20
GSK1841157
GSK 1841157
UNII-M95KG522R0
Arzerra
HuMax-CD20, 2F2
Arzerra Injection
HSDB 8170 CAS 679818-59-8
Purity 97%+In StockPharmaceutical Standards
CAS No.
679818-59-8
Molecular Formula
C12H10N4O2
Molecular Weight
242.23 g/mol
Category
Pharmaceutical Standards / API Standards
Availability
In Stock
Chemical Structure
Description
679818-59-8
M95KG522R0
Ofatumumab [USAN:INN:BAN:JAN]
Immunoglobulin G1, anti-(human CD20 (antigen))(human monoclonal HuMax-CD20 heavy chain), disulfide with human monoclonal HuMax-CD20 kappa-chain, dimer
Ofatumumab
HuMax-CD20
GSK1841157
GSK 1841157
UNII-M95KG522R0
Arzerra
HuMax-CD20, 2F2
Arzerra Injection
HSDB 8170 (CAS 679818-59-8) is a high-purity pharmaceutical standards reference standard from CATO, an ISO 17034 accredited reference material producer. Molecular formula: C12H10N4O2. Molecular weight: 242.23 g/mol. Each batch is supplied with a Certificate of Analysis (COA).
Physical & Chemical Properties
Molecular Formula
C12H10N4O2
Molecular Weight
242.23 g/mol
Appearance
Pale yellow to yellow crystalline powder
Purity
97%+
Storage
Store at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)
Soluble in DMSO, DMF, methanol
Stability
May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening